The new data, published this week in JAMA Network Open, show that after adjusting for multiple variables, COVID-19 patients treated with ACE inhibitors and ARBs had a significantly lower risk of death ...

April 26 (UPI) --Taking a specific type of blood pressure medication increases levels of a protein that helps COVID-19 spread through the body, a study presented Monday during the American Society for ...

A high-profile study that purported to provide the first reassurances ACE inhibitors and ARBs could be safely used in the setting of COVID-19 continues to be cited long after it was retracted over ...

* EMA - REITERATES ITS PREVIOUS ADVICE THAT PATIENTS SHOULD CONTINUE TO USE ACE INHIBITORS OR ARBS AS ADVISED BY THEIR DOCTORS * EMA - RECENT OBSERVATIONAL STUDIES OF ACE INHIBITORS AND ARBS HAVE NOT ...

Hyperkalemia Risk May Be Higher With MRA-RAAS Inhibitor Combo Three studies published in the New England Journal of Medicine on May found no evidence that the use of ACE inhibitors or ...

As one of the major targets of Covid-19, infection in the kidneys can led to significant complications associated with kidney disease, as well as kidney failure. Kidney damage can occur even in those ...

A recent study posted to the medRxiv* preprint server investigated the association of renin-angiotensin-aldosterone system (RAAS)-mediated hypertension (HT) with coronavirus disease 2019 (COVID-19).